94 related articles for article (PubMed ID: 19606194)
21. Seroprevalence of cytomegalovirus antibodies among blood donors and Multitransfused recipients--a study from north India.
Das B; Kaur G; Basu S
Transfus Apher Sci; 2014 Jun; 50(3):438-42. PubMed ID: 24675015
[TBL] [Abstract][Full Text] [Related]
22. Acute cytomegalovirus infections in blood donors are indicated by increased serum neopterin concentrations.
Schennach H; Hessenberger G; Mayersbach P; Schönitzer D; Fuchs D
Med Microbiol Immunol; 2002 Oct; 191(2):115-8. PubMed ID: 12410351
[TBL] [Abstract][Full Text] [Related]
23. Direct assessment of cytomegalovirus transfusion-transmitted risks after universal leukoreduction.
Wu Y; Zou S; Cable R; Dorsey K; Tang Y; Hapip CA; Melmed R; Trouern-Trend J; Wang JH; Champion M; Fang C; Dodd R
Transfusion; 2010 Apr; 50(4):776-86. PubMed ID: 19912585
[TBL] [Abstract][Full Text] [Related]
24. High prevalence of cytomegalovirus DNA in plasma samples of blood donors in connection with seroconversion.
Ziemann M; Krueger S; Maier AB; Unmack A; Goerg S; Hennig H
Transfusion; 2007 Nov; 47(11):1972-83. PubMed ID: 17958525
[TBL] [Abstract][Full Text] [Related]
25. [Antibodies to cytomegaloviruses in blood donors].
Courault K; Lissé I; Richter H
Folia Haematol Int Mag Klin Morphol Blutforsch; 1989; 116(2):183-6. PubMed ID: 2475395
[TBL] [Abstract][Full Text] [Related]
26. Diagnostic value of enzyme linked immuno-sorbent assay for cytomegalovirus disease.
Priya K; Madhavan HN
J Postgrad Med; 2002; 48(3):176-8; discussion 190. PubMed ID: 12432189
[TBL] [Abstract][Full Text] [Related]
27. CMV antibody prevalence and seroincidence in plateletpheresis donors.
Boeke CE; Pauly ME; Hatch-Stock H; Jackson JB
J Clin Apher; 2008; 23(2):63-5. PubMed ID: 18181166
[TBL] [Abstract][Full Text] [Related]
28. [Prevalence of antibodies against CMV in Grenada].
Rojo MD; García MV; Oyonarte S; Mendoza J; Carazo C; Fernández-Montoya A
Sangre (Barc); 1992 Aug; 37(4):293-5. PubMed ID: 1325073
[TBL] [Abstract][Full Text] [Related]
29. Prevalence of cytomegalovirus seropositivity in an urban childhood population in Cameroon.
Stroffolini T; Ngatchu T; Chiaramonte M; Giammanco A; Maggio M; Sarzana A; Taormina S
New Microbiol; 1993 Jan; 16(1):83-5. PubMed ID: 8385733
[TBL] [Abstract][Full Text] [Related]
30. The prevalence of human cytomegalovirus seropositivity among blood donors at the Unit of Blood Transfusion Medicine, Hospital Universiti Sains Malaysia.
Ahmed SA; Al-Joudi FS; Zaidah AW; Roshan TM; Rapiaah M; Abdullah YM; Rosline H
Southeast Asian J Trop Med Public Health; 2006 Mar; 37(2):294-6. PubMed ID: 17124989
[TBL] [Abstract][Full Text] [Related]
31. Validation of an automated immunoglobulin G-only cytomegalovirus (CMV) antibody screening assay and an assessment of the risk of transfusion transmitted CMV from seronegative blood.
Seed CR; Piscitelli LM; Maine GT; Lazzarotto T; Doherty K; Stricker R; Stricker R; Iriarte B; Patel C
Transfusion; 2009 Jan; 49(1):134-45. PubMed ID: 18954407
[TBL] [Abstract][Full Text] [Related]
32. [CMV antibody determination with two enzyme immunoassays in each case].
Albert S; Sibrowski W; Kühnl P; Knödler B; Seidl S; Böhm BO; Doerr HW
Beitr Infusionsther; 1990; 26():40-2. PubMed ID: 1703884
[TBL] [Abstract][Full Text] [Related]
33. Prevalence of transmissible blood infections among blood donors at the University of Maiducuri Teaching Hospital, Maiduguri, Nigeria.
Chikwem JO; Mohammed I; Okara GC; Ukwandu NC; Ola TO
East Afr Med J; 1997 Apr; 74(4):213-6. PubMed ID: 9299819
[TBL] [Abstract][Full Text] [Related]
34. [Prevalence of anti-CMV antibodies in blood donors in the Sfax region (value in blood transfusion)].
Gargouri J; Elleuch H; Karray H; Rekik H; Hammami A
Tunis Med; 2000; 78(8-9):512-7. PubMed ID: 11190729
[TBL] [Abstract][Full Text] [Related]
35. Determination of cytomegalovirus antibody titers in sera of volunteer blood donors by use of complement fixation and two immunoenzymatic tests.
Dzierzanowska D; Kołodziejczyk J; Lourie I
Arch Immunol Ther Exp (Warsz); 1986; 34(4):397-402. PubMed ID: 3026277
[TBL] [Abstract][Full Text] [Related]
36. Survey the seroprevalence of CMV among hemodialysis patients in Urmia, Iran.
Sepehrvand N; Khameneh ZR; Eslamloo HR
Saudi J Kidney Dis Transpl; 2010 Mar; 21(2):363-7. PubMed ID: 20228534
[TBL] [Abstract][Full Text] [Related]
37. Seroprevalence of HIV infection among blood donors in Port Harcourt, Nigeria.
Ejele OA; Nwauche CA; Erhabor O
Niger J Med; 2005; 14(3):287-9. PubMed ID: 16350699
[TBL] [Abstract][Full Text] [Related]
38. [Prevalence of anti-CMV antibodies in blood donors in Ouagadougou (Burkina Faso)].
Ouédraogo AS; Yaméogo JT; Poda GE; Kientega Y; Ouédraogo Traore R
Med Sante Trop; 2012; 22(1):107-9. PubMed ID: 22871792
[TBL] [Abstract][Full Text] [Related]
39. Impact of highly active antiretroviral therapy on cytomegalovirus viraemia in the absence of specific anti-cytomegalovirus therapy.
Mihăilescu R; Arama V; Paraschiv S; Streinu-Cercel A; Oţelea D; Munteanu D; Iosipenco M; Chiotan C; Benea OE; Mărdărescu M; Rădulescu M; Hristea A; Ungurianu R; Aramă SS; Cercel AS; Călin R; Băicuş C
Rom J Intern Med; 2008; 46(4):305-11. PubMed ID: 19480296
[TBL] [Abstract][Full Text] [Related]
40. A study on the epidemiology of hepatitis C infection among blood donors in Singapore.
Wang JE
J Public Health Med; 1995 Dec; 17(4):387-91. PubMed ID: 8639336
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
